GKOS - Glaukos Corporation
Close
133.89
1.300 0.971%
Share volume: 356,313
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$132.59
1.30
0.98%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-04 | 2023-02-24 | 2023-05-04 | 2023-08-02 | 2023-11-01 | 2024-02-23 | 2024-05-03 | 2024-08-02 | |
Assets | |||||||||
Total Assets | 1.008 B | 1.002 B | 972.592 M | 956.740 M | 948.634 M | 940.414 M | 933.338 M | 919.675 M | |
Current Assets | 448.841 M | 443.859 M | 415.880 M | 401.260 M | 399.529 M | 395.461 M | 388.610 M | 383.781 M | |
Inventories | 34.182 M | 37.841 M | 40.455 M | 39.447 M | 39.781 M | 41.986 M | 50.185 M | 56.480 M | |
Other Current Assets | 18.275 M | 17.250 M | 19.804 M | 18.754 M | 19.565 M | 18.194 M | 19.020 M | 14.420 M | |
Short Term Investments | 18.275 M | 17.250 M | 19.804 M | 18.754 M | 19.565 M | 18.194 M | 19.020 M | 14.420 M | |
Total Receivables | 34.766 M | 36.073 M | 37.852 M | 39.252 M | 39.326 M | 39.850 M | 46.545 M | 51.217 M | |
Current Cash | 361.618 M | 352.695 M | 317.769 M | 303.807 M | 300.857 M | 295.431 M | 272.860 M | 261.664 M | |
Total Non-current Assets | 559.627 M | 558.524 M | 556.712 M | 555.480 M | 549.105 M | 544.953 M | 544.728 M | 535.894 M | |
Property Plant Equipment | 87.307 M | 94.403 M | 98.331 M | 102.674 M | 103.075 M | 103.212 M | 101.858 M | 100.230 M | |
Other Assets | 56.962 M | 57.214 M | 56.889 M | 57.678 M | 57.583 M | 59.649 M | 62.278 M | 62.694 M | |
Intangible Assets | 314.097 M | 307.869 M | 301.640 M | 295.412 M | 289.184 M | 282.956 M | 281.919 M | 275.673 M | |
Goodwill | 66.134 M | 66.134 M | 66.134 M | 66.134 M | 66.134 M | 66.134 M | 66.134 M | 66.134 M | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 1.008 B | 1.002 B | 972.592 M | 956.740 M | 948.634 M | 940.414 M | 933.338 M | 919.675 M | |
Total liabilities | 459.914 M | 472.378 M | 464.078 M | 467.929 M | 470.975 M | 478.648 M | 482.608 M | 254.516 M | |
Total current liabilities | 60.615 M | 72.359 M | 62.392 M | 63.886 M | 67.147 M | 74.014 M | 72.238 M | 70.083 M | |
Accounts Payable | 11.465 M | 14.403 M | 12.029 M | 8.564 M | 10.413 M | 13.440 M | 12.752 M | 11.560 M | |
Other liabilities | 9.494 M | 10.278 M | 11.186 M | 12.905 M | 12.793 M | 13.752 M | 19.710 M | 20.678 M | |
Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Long term debt | 353.375 M | 353.572 M | 353.766 M | 353.110 M | 353.214 M | 353.311 M | 353.406 M | 126.701 M | |
Other liabilities | 9.494 M | 10.278 M | 11.186 M | 12.905 M | 12.793 M | 13.752 M | 19.710 M | 20.678 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 548.554 M | 530.005 M | 508.514 M | 488.811 M | 477.659 M | 461.766 M | 450.730 M | 665.159 M | |
Common stock | 47.614 M | 47.756 M | 47.881 M | 48.281 M | 48.675 M | 48.895 M | 49.580 M | 50.715 M | |
Retained earnings | -432.946 M | -464.406 M | -499.032 M | -531.844 M | -562.288 M | -599.067 M | -639.905 M | -690.450 M |